$MMEX
MMEX Resources Corp Stock $mmex

$mmex Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000147793223005360 Filed on July 17, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$324.0K	$300.8K	$1.680M
YoY Change	-59.69%	-0.5%	29.87%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.100K	$9.090K	$36.39K
YoY Change	0.0%	0.66%	1.43%
% of Gross Profit
Operating Expenses	$333.1K	$307.9K	$1.811M
YoY Change	-59.24%	-45.64%	-38.91%
Operating Profit	-$333.1K		-$1.811M
YoY Change	-59.24%		-38.91%
Interest Expense	$99.14K	-$41.70K	-$234.9K
YoY Change	-257.64%	-79.75%	-109.42%
% of Operating Profit
Other Income/Expense, Net	-$852.4K		-$168.5K
YoY Change	1739.21%		-106.16%
Pretax Income	-$1.186M	-$299.7K	-$1.979M
YoY Change	37.27%	-60.69%	765.42%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.186M	-$308.7K	-$4.523M
YoY Change	37.27%	-59.51%	1877.39%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	-$0.05
COMMON SHARES
Basic Shares Outstanding	4.541B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$250.00	$10.36K	$10.36K
YoY Change	-96.97%	-92.43%	-92.43%
Cash & Equivalents	$250.00	$10.36K
Short-Term Investments
Other Short-Term Assets	$3.000K	$24.00K	$24.00K
YoY Change	-89.94%	-49.29%	-49.29%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.250K	$34.36K	$34.36K
YoY Change	-91.47%	-81.35%	-81.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.069M	$1.078M	$1.078M
YoY Change	-3.29%	-3.27%	-3.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change
Total Long-Term Assets	$1.069M	$1.078M	$1.078M
YoY Change	-3.29%	-3.27%	-3.27%
TOTAL ASSETS
Total Short-Term Assets	$3.250K	$34.36K	$34.36K
Total Long-Term Assets	$1.069M	$1.078M	$1.078M
Total Assets	$1.072M	$1.112M	$1.112M
YoY Change	-6.23%	-14.34%	-14.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$754.4K	$1.200M	$1.200M
YoY Change	13.8%	87.5%	87.5%
Accrued Expenses	$1.049M	$985.8K	$985.8K
YoY Change	21.4%	15.8%	15.8%
Deferred Revenue
YoY Change
Short-Term Debt	$1.790M	$1.792M	$1.792M
YoY Change	17.44%	20.56%	20.56%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.025M	$3.977M	$3.977M
YoY Change	27.45%	30.22%	30.22%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.025M	$3.977M	$3.977M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.025M	$3.987M	$3.987M
YoY Change	27.45%	30.55%	30.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.91M	-$72.73M
YoY Change	3.21%	6.62%
Common Stock	$4.881M	$769.6K
YoY Change	19897.37%	3529.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.953M	-$2.875M	-$2.875M
YoY Change
Total Liabilities & Shareholders Equity	$1.072M	$1.112M	$1.112M
YoY Change	-6.23%	-14.34%	-14.34%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$1.186M	-$308.7K	-$4.523M
YoY Change	37.27%	-59.51%	1877.39%
Depreciation, Depletion And Amortization	$9.100K	$9.090K	$36.39K
YoY Change	0.0%	0.66%	1.43%
Cash From Operating Activities	-$75.51K	-$62.15K	-$682.0K
YoY Change	-67.68%	-86.37%	-79.96%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$41.21K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$65.40K	65.00K	555.5K
YoY Change	-37.71%	-45.62%	-85.71%
NET CHANGE
Cash From Operating Activities	-$75.51K	-62.15K	-682.0K
Cash From Investing Activities	$0.00	0.000	0.000
Cash From Financing Activities	$65.40K	65.00K	555.5K
Net Change In Cash	-$10.11K	2.850K	-126.5K
YoY Change	-92.14%	-100.38%	-34.65%
FREE CASH FLOW
Cash From Operating Activities	-$75.51K	-$62.15K	-$682.0K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$75.51K	-$62.15K	-$682.0K
YoY Change	-67.68%	84.48%	-83.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	47333	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	184200	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1114197	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0	usd
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	900	usd
CY2023Q2	us-gaap	Assets Assets	1112166	usd
CY2022Q2	us-gaap	Assets Assets	1298397	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	733857	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	639782	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	985751	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	851275	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001440799
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	mmex	Convertible Notes Net Of Discount Currently In Default ConvertibleNotesNetOfDiscountCurrentlyInDefault	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21204682	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-04-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-152608
CY2023	dei	Entity Registrant Name EntityRegistrantName	MMEX RESOURCES CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1749145
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3600 Dickinson
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Fort Stockton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78735
CY2023	dei	City Area Code CityAreaCode	855
CY2023	dei	Local Phone Number LocalPhoneNumber	880-0400
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	416000	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4541221023	shares
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Location AuditorLocation	Houston, TX
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	136867	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	465703	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	76770	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	904452	usd
CY2023Q2	us-gaap	Debt Default Shortterm Debt Amount DebtDefaultShorttermDebtAmount	711953	usd
CY2022Q2	us-gaap	Debt Default Shortterm Debt Amount DebtDefaultShorttermDebtAmount	75001	usd
CY2023Q2	mmex	Convertible Notes Net Of Discount Currently In Default ConvertibleNotesNetOfDiscountCurrentlyInDefault	0	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	333840	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	75000	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	15200	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	22903	usd
CY2023Q2	mmex	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	620675	usd
CY2022Q2	mmex	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	432097	usd
CY2023Q2	mmex	Convertible Notes Payable Related Party Net Of Discount ConvertibleNotesPayableRelatedPartyNetOfDiscount	0	usd
CY2022Q2	mmex	Convertible Notes Payable Related Party Net Of Discount ConvertibleNotesPayableRelatedPartyNetOfDiscount	0	usd
CY2023Q2	mmex	Convertible Debt Related Parties Current ConvertibleDebtRelatedPartiesCurrent	20000	usd
CY2022Q2	mmex	Convertible Debt Related Parties Current ConvertibleDebtRelatedPartiesCurrent	0	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3054377	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3054377	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	769618295	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21204682	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	21205	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66426364	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	9871	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68213423	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1755980	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1298397	usd
CY2023	mmex	Cost Incurred On Refinery Start Up CostIncurredOnRefineryStartUp	94556	usd
CY2022	mmex	Cost Incurred On Refinery Start Up CostIncurredOnRefineryStartUp	1637742	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	3010042	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	66413	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	243303	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-168481	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2735561	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1979480	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-228730	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1979480	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-228730	usd
CY2023	us-gaap	Dividends Dividends	2543402	usd
CY2022	us-gaap	Dividends Dividends	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4513882	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-228730	usd
CY2023	mmex	Net Income Loss Per Common Share Basic And Diluted NetIncomeLossPerCommonShareBasicAndDiluted	-0.05
CY2022	mmex	Net Income Loss Per Common Share Basic And Diluted NetIncomeLossPerCommonShareBasicAndDiluted	-0.02
CY2023	mmex	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	96783122	shares
CY2022	mmex	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	12820881	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-5770041	usd
CY2022	mmex	Share Issued With Prefunded Warrants For Cash Amount ShareIssuedWithPrefundedWarrantsForCashAmount	3000000	usd
CY2022	mmex	Shares Issued For Accrued Expenses Amount SharesIssuedForAccruedExpensesAmount	15000	usd
CY2022	mmex	Shares Issued For Accrued Expenses Related Parties Amount SharesIssuedForAccruedExpensesRelatedPartiesAmount	40000	usd
CY2022	mmex	Shares Issued For Debt Discount Amount SharesIssuedForDebtDiscountAmount	14091	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	154438	usd
CY2022	mmex	Shares Issued Convertible Notes Payable Related Parties Amount SharesIssuedConvertibleNotesPayableRelatedPartiesAmount	74989	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1500000	usd
CY2022	mmex	Shares Issued For The Exercise Of Prefunded Warrants Amount SharesIssuedForTheExerciseOfPrefundedWarrantsAmount	0	usd
CY2022	mmex	Shares Issued For The Exercise Of Series A Warrants Amount SharesIssuedForTheExerciseOfSeriesAWarrantsAmount	73	usd
CY2022	mmex	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits	0	usd
CY2022	mmex	Offering Costs OfferingCosts	-555800	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-228730	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1755980	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1755980	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	327367	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	41209	usd
CY2023	mmex	Shares Issued For Accrued Expenses Related Parties Amount SharesIssuedForAccruedExpensesRelatedPartiesAmount	1006	usd
CY2023	mmex	Shares And Warrants Issued For Debt Discount Amount SharesAndWarrantsIssuedForDebtDiscountAmount	17371	usd
CY2023	mmex	Shares Issued For The Exercise Of Warrants Amount SharesIssuedForTheExerciseOfWarrantsAmount	184	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	495000	usd
CY2023	mmex	Offering Costs OfferingCosts	-12000	usd
CY2023	mmex	Deemed Dividends DeemedDividends	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1979480	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2865323	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1979480	usd
CY2022	us-gaap	Profit Loss ProfitLoss	228730	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36394	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35877	usd
CY2023	mmex	Loan Fees And Penalties Added To Convertible Note LoanFeesAndPenaltiesAddedToConvertibleNote	53126	usd
CY2022	mmex	Loan Fees And Penalties Added To Convertible Note LoanFeesAndPenaltiesAddedToConvertibleNote	165000	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	495000	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	3010042	usd
CY2023	mmex	Gains Loss On Extinguishment Of Debt GainsLossOnExtinguishmentOfDebt	66412	usd
CY2022	mmex	Gains Loss On Extinguishment Of Debt GainsLossOnExtinguishmentOfDebt	243303	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	53533	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	79011	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-23333	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	9440	usd
CY2023	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	0	usd
CY2022	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	900	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	94075	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-116277	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	198488	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	80497	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	409939	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-156064	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-682004	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3402571	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	677905	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-677905	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	15000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	352500	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	388048	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	552500	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	233500	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	41209	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	255331	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	41209	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	1500000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	73	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	12000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	555800	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	555500	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3886894	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-126504	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-193582	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136867	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	330449	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10363	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136867	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3310	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	164135	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	mmex	Common Stock Issued In Conversion Of Debt CommonStockIssuedInConversionOfDebt	376067	usd
CY2022	mmex	Common Stock Issued In Conversion Of Debt CommonStockIssuedInConversionOfDebt	154438	usd
CY2023	mmex	Common Stock Issued In Conversion Of Related Party Debt CommonStockIssuedInConversionOfRelatedPartyDebt	0	usd
CY2022	mmex	Common Stock Issued In Conversion Of Related Party Debt CommonStockIssuedInConversionOfRelatedPartyDebt	74989	usd
CY2023	mmex	Common Stock Issued For Accrued Expenses CommonStockIssuedForAccruedExpenses	0	usd
CY2022	mmex	Common Stock Issued For Accrued Expenses CommonStockIssuedForAccruedExpenses	15000	usd
CY2023	mmex	Common Stock Issued For Accrued Expenses Related Parties CommonStockIssuedForAccruedExpensesRelatedParties	1006	usd
CY2022	mmex	Common Stock Issued For Accrued Expenses Related Parties CommonStockIssuedForAccruedExpensesRelatedParties	40000	usd
CY2023	mmex	Preferred Stock Converted Into Common Stock PreferredStockConvertedIntoCommonStock	528020	usd
CY2022	mmex	Preferred Stock Converted Into Common Stock PreferredStockConvertedIntoCommonStock	0	usd
CY2023	mmex	Deemed Dividend DeemedDividend	2534402	usd
CY2022	mmex	Deemed Dividend DeemedDividend	0	usd
CY2023	mmex	Non Cash Exercises Of Warrants NonCashExercisesOfWarrants	14343	usd
CY2022	mmex	Non Cash Exercises Of Warrants NonCashExercisesOfWarrants	0	usd
CY2023	mmex	Warrants Exercises For An Accrued Liability WarrantsExercisesForAnAccruedLiability	184	usd
CY2022	mmex	Warrants Exercises For An Accrued Liability WarrantsExercisesForAnAccruedLiability	0	usd
CY2023	mmex	Reverse Stock Split ReverseStockSplit	0	usd
CY2022	mmex	Reverse Stock Split ReverseStockSplit	18	usd
CY2023	mmex	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	0	usd
CY2022	mmex	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	3580	usd
CY2023	mmex	Shares And Warrants Issued For Debt Discount SharesAndWarrantsIssuedForDebtDiscount	17371	usd
CY2022	mmex	Shares And Warrants Issued For Debt Discount SharesAndWarrantsIssuedForDebtDiscount	14091	usd
CY2023	mmex	Note Payable For Convertible Note Payable NotePayableForConvertibleNotePayable	190249	usd
CY2022	mmex	Note Payable For Convertible Note Payable NotePayableForConvertibleNotePayable	0	usd
CY2023	mmex	Related Party Accounts Payable Exchanged For Related Party Convertible Note RelatedPartyAccountsPayableExchangedForRelatedPartyConvertibleNote	20000	usd
CY2022	mmex	Related Party Accounts Payable Exchanged For Related Party Convertible Note RelatedPartyAccountsPayableExchangedForRelatedPartyConvertibleNote	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	18398	usd
CY2023	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	20000	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	3010042	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3543	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	495000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Certain amounts in the consolidated financial statements for the prior year have been reclassified to conform with the current year presentation.</p>
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72727305	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2865323	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10363	usd
CY2023Q2	mmex	Working Capital Deficit WorkingCapitalDeficit	-3943126	usd
CY2023Q2	mmex	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	465703	usd
CY2022Q2	mmex	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	76770	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2023Q2	mmex	Convertible Notes Payables ConvertibleNotesPayables	20000	usd
CY2022Q2	mmex	Convertible Notes Payables ConvertibleNotesPayables	0	usd
CY2023Q1	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	20000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.10	pure
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	175	usd
CY2023Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	175	usd
CY2022	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1247877	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1258839	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	170074	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	144642	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1077803	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1114197	usd
CY2022	mmex	Conversion Of Stock Shares Of Related Party Converted1 ConversionOfStockSharesOfRelatedPartyConverted1	6817224	shares
CY2022	mmex	Convertible Common Stock Converted To Other Securities ConvertibleCommonStockConvertedToOtherSecurities	74989	usd
CY2022	mmex	Common Stock Shares Issued Upon Conversion Of Debt Shares CommonStockSharesIssuedUponConversionOfDebtShares	17754	usd
CY2022	mmex	Shares Issued For Exercise Of Prefunded Warrants SharesIssuedForExerciseOfPrefundedWarrants	3580000	shares
CY2022	mmex	Warrants Issued For Debt Discount WarrantsIssuedForDebtDiscount	337500	shares
CY2022	mmex	Out Of Pocket Offering Costs OutOfPocketOfferingCosts	349150	usd
CY2023Q2	us-gaap	Debt Default Shortterm Debt Amount DebtDefaultShorttermDebtAmount	711953	usd
CY2022Q2	us-gaap	Debt Default Shortterm Debt Amount DebtDefaultShorttermDebtAmount	75001	usd
CY2021Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-03-11
CY2021Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	113048	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	105710	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	904452	usd
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1000000	usd
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	250000	usd
CY2021Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
CY2023Q2	mmex	Convertible Notes Payable Currently In Default ConvertibleNotesPayableCurrentlyInDefault	333840	usd
CY2022Q2	mmex	Convertible Notes Payable Currently In Default ConvertibleNotesPayableCurrentlyInDefault	75000	usd
CY2023Q2	mmex	Convertible Notes Payable Discount ConvertibleNotesPayableDiscount	0	usd
CY2022Q2	mmex	Convertible Notes Payable Discount ConvertibleNotesPayableDiscount	0	usd
CY2023Q2	mmex	Convertible Notes Payable Currently In Default Net Of Discount ConvertibleNotesPayableCurrentlyInDefaultNetOfDiscount	333840	usd
CY2022Q2	mmex	Convertible Notes Payable Currently In Default Net Of Discount ConvertibleNotesPayableCurrentlyInDefaultNetOfDiscount	75000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	165000	usd
CY2022Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	155000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	10000	usd
CY2023Q2	mmex	Convertible Notes Payable Total ConvertibleNotesPayableTotal	635875	usd
CY2022Q2	mmex	Convertible Notes Payable Total ConvertibleNotesPayableTotal	455000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	15200	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	22903	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	620675	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	432097	usd
CY2023	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	710802	shares
CY2023	mmex	Gains Losses On Settlement Of Debt GainsLossesOnSettlementOfDebt	16540	usd
CY2022Q2	mmex	Note Desceription NoteDesceription	The Company can prepay the note with prepayment penalties ranging from 105% to 125% during the first 180 days after issuance. During the year ended April 30, 2023 the Company converted $64,950 into 137,891,070 shares of common stock based on the variable conversion prices in effect on the date of the conversions
CY2023Q2	mmex	Capital Stock Authorized CapitalStockAuthorized	10001000000	shares
CY2022Q2	mmex	Capital Stock Authorized CapitalStockAuthorized	201000000	shares
CY2023Q2	mmex	Common Stock Share Authorized CommonStockShareAuthorized	10000000000	shares
CY2022Q2	mmex	Common Stock Share Authorized CommonStockShareAuthorized	200000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023	mmex	Total Shares Issued Of Common Stock TotalSharesIssuedOfCommonStock	748413613	shares
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	202640220	shares
CY2023	mmex	Common Stock Shares Issued For Conversion Of Convertible Note Value CommonStockSharesIssuedForConversionOfConvertibleNoteValue	338700	usd
CY2023	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	373367	usd
CY2023	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	34667	usd
CY2023	mmex	Payment Of Fee Value PaymentOfFeeValue	2700	usd
CY2023	mmex	Shares Issued Prefunded Warrants SharesIssuedPrefundedWarrants	1373562	shares
CY2023	mmex	Warrants To Purchase Share WarrantsToPurchaseShare	686281	shares
CY2023	mmex	Convertible Common Stock Converted To Other Securities ConvertibleCommonStockConvertedToOtherSecurities	41209	usd
CY2023	mmex	Out Of Pocket Offering Costs OutOfPocketOfferingCosts	12000	usd
CY2023	mmex	Shares Issued For Accrued Liability Related Parties Share SharesIssuedForAccruedLiabilityRelatedPartiesShare	91414	shares
CY2023	mmex	Shares Issued For Accrued Liability Related Parties Value SharesIssuedForAccruedLiabilityRelatedPartiesValue	1006	usd
CY2023	mmex	Warrants Issued For Debt Discount WarrantsIssuedForDebtDiscount	235109718	shares
CY2023Q2	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	17371	usd
CY2023	mmex	Shares Issued For Exercise Of Prefunded Warrants SharesIssuedForExerciseOfPrefundedWarrants	16188264	shares
CY2023	mmex	Warrants Issued For Conversion Of Series B Preferred Stock WarrantsIssuedForConversionOfSeriesBPreferredStock	528020153	shares
CY2023	mmex	Conversion Of Stock Shares Of Related Party Converted1 ConversionOfStockSharesOfRelatedPartyConverted1	356	shares
CY2022	mmex	Total Shares Issued Of Common Stock TotalSharesIssuedOfCommonStock	17953041	shares
CY2022	mmex	Share Issued During Period Shares ShareIssuedDuringPeriodShares	170000	shares
CY2022	mmex	Shares Issued Prefunded Warrants SharesIssuedPrefundedWarrants	3580000	shares
CY2022	mmex	Warrants To Purchase Share WarrantsToPurchaseShare	2575500	shares
CY2022	mmex	Stock Issued During Period Value New Issuesfor Cash StockIssuedDuringPeriodValueNewIssuesforCash	3000000	usd
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	6433743	shares
CY2022	mmex	Common Stock Shares Issued For Conversion Of Convertible Note Value CommonStockSharesIssuedForConversionOfConvertibleNoteValue	154438	usd
CY2022	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	149444	usd
CY2022	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	4490	usd
CY2022	us-gaap	Payments For Fees PaymentsForFees	504	usd
CY2022Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.10
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.05
CY2023	mmex	Warrant Grant WarrantGrant	3000000	shares
CY2023	mmex	Warrants Issued As Stock Based Compensation WarrantsIssuedAsStockBasedCompensation	495000	usd
CY2023	mmex	Warrants Modified The Terms Of Description WarrantsModifiedTheTermsOfDescription	Series C and Series D warrants, from $0.10 to $0.05
CY2023	mmex	Warrants Conjuction With Sale WarrantsConjuctionWithSale	686281	shares
CY2023	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	686281	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.045
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	15000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	11991	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	235109718	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0000638
CY2023	mmex	Warrants Term WarrantsTerm	five-year
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	769618295	shares
CY2023	mmex	Net Operating Loss Carryforwards NetOperatingLossCarryforwards	21669158	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.50	pure
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4550523	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4132196	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4550523	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4132196	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	mmex	Change In Net Operating Loss Benefit ChangeInNetOperatingLossBenefit	418328	usd
CY2022	mmex	Change In Net Operating Loss Benefit ChangeInNetOperatingLossBenefit	714644	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-418328	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-714644	usd
CY2023	mmex	Icome Tax Expense IcomeTaxExpense	0	usd
CY2022	mmex	Icome Tax Expense IcomeTaxExpense	0	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	60000	usd
CY2023Q2	mmex	Waarrant Issued WaarrantIssued	300000000	shares
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	256708619	shares
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	12950	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1399	usd
CY2023Q2	mmex	Accrued Fees AccruedFees	540	usd
CY2023	mmex	Shares Issued For Accrued Liabilities SharesIssuedForAccruedLiabilities	279120377	shares
CY2023	mmex	Shares Issued For Accrued Liabilities Amount SharesIssuedForAccruedLiabilitiesAmount	17808	usd
CY2023	mmex	Share Issued For Conversion Of Preferred Stock ShareIssuedForConversionOfPreferredStock	301724139	shares
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	20000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	25400	usd

Files In Submission

Name	View Source	Status
0001477932-23-005360-index-headers.html	Edgar Link	pending
0001477932-23-005360-index.html	Edgar Link	pending
0001477932-23-005360.txt	Edgar Link	pending
0001477932-23-005360-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mmex-20230430.xsd	Edgar Link	pending
mmex_10k.htm	Edgar Link	pending
mmex_10kimg3.jpg	Edgar Link	pending
mmex_ex311.htm	Edgar Link	pending
mmex_ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
mmex-20230430_lab.xml	Edgar Link	unprocessable
mmex-20230430_def.xml	Edgar Link	unprocessable
mmex-20230430_pre.xml	Edgar Link	unprocessable
mmex_10k_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mmex-20230430_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MMEX
MMEX Resources Corp Stock $mmex

2023 Q3 Form 10-K Financial Statement

#000147793223005360 Filed on July 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMEX MMEX Resources Corp Stock $mmex

2023 Q3 Form 10-K Financial Statement

#000147793223005360 Filed on July 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMEX
MMEX Resources Corp Stock $mmex